Biopharma Capabilities

Supporting Biopharma Across the Therapy Lifecycle

Over the last 20 years, McKesson has been advancing cancer care by empowering community providers to maintain their independence so patients can get high-quality care closer to home, while partnering with biopharma to accelerate the development and delivery of the next generation of therapies.

As one of the largest distributors of oncology and specialty medicines, we support the drug lifecycle through separate, non-clinical capabilities to ensure therapies are delivered safely and reliably. Our solutions and services focus on removing barriers that can stand between patients and treatment.

Our Biopharma Capabilities at a Glance

We’re helping new therapies reach patients and enabling care teams to stay focused on what matters most.

Practices in The Network treat more than 2 million patients each year.

Over 20,000 patients supported across Phase I–IV clinical trials enabled through McKesson‑supported clinical research and trial solutions.¹

More than 3,400 patients enrolled annually in cancer clinical trials through Sarah Cannon Research Institute (SCRI).¹

More than 10 years supporting cell and gene therapy programs across complex development and delivery pathways.¹

Our Biopharma Businesses

Our services and solutions are supported by physician education, technology enhanced by artificial intelligence, and real‑world data and insights to accelerate clinical development, support evidence‑based commercialization planning and expand patient access.

Providing access, affordability, insights and technology services

A person in a white coat works at a computer in an office with a printer on the desk.

CoverMyMeds streamlines the entire therapy journey by connecting services like electronic prior authorization, benefits verification, affordability support and other support services, making it easier for patients to start treatment and stay on it.

Learn More

A blurred face with digital interface elements like circular graphics and bar charts around the head.

McKesson Compile provides longitudinal patient‑journey data and analytics that help biopharma companies develop and commercialize therapies using real‑world insights.

Learn More

Accelerating the next generation of therapies and clinical trials

The US Oncology Network streamlines logistical and administrative access to complex therapies, supporting timely, high‑quality care for patients.

Ontada provides real-world oncology data, research and provider education to accelerate drug development, inform market strategies and improve health outcomes.

Sarah Cannon Research Institute (SCRI) partners with biopharma companies to advance the science of cancer treatments.

Biologics by McKesson provides specialty pharmacy services simplifying access to therapies and delivers personalized, high-touch support for cancer, cell and gene and rare disease patients.

InspiroGene delivers complex cell and gene therapies directly to patients and providers, advancing innovative treatment delivery.

Genospace advances precision medicine by enabling clinical trial matching in community practices.

Supporting physician education and logistics support

McKesson Medical-Surgical delivers therapies and lab products accurately, safely, securely and on time.

Clinical Research Services and Clinical Trial Solutions supports the commercialization of medications by simplifying clinical trial logistics.

McKesson Product Awareness Services provides pharmacy awareness and education programs.

McKesson Third Party Logistics® ensures lifesaving therapies arrive safely, efficiently and on time.

Our Group Purchasing Organization Strategies help practices lower their drug costs and support access to advanced therapies.

Who We Serve

McKesson’s biopharma capabilities help manufacturers move therapies from clinical development to commercialization — connecting clinical research, real-world evidence, distribution and patient access support so more patients can start and stay on treatment.

McKesson provides 3PL logistics, cold‑chain and specialty distribution and GPO management to ensure reliable product availability across its nationwide provider network.

McKesson delivers end‑to‑end commercialization support that integrates specialty distribution, specialty pharmacy and real‑world data to speed access and prove value.

McKesson offers right‑sized launch packages combining distribution, patient support programs and specialty pharmacy with the flexibility teams need for first launches.

McKesson helps life sciences organizations connect evidence to execution by using real‑world data, provider networks and integrated clinical‑to‑commercial coordination to inform strategy and scale access.

For established pharma, McKesson provides scaled specialty distribution and patient services, access enablement through provider networks and GPOs, and real-world evidence to support market access.

Open reports with charts, graphs, and text discussing clinical trial design and community engagement.

Advancing Community Oncology Report

Explore the 2025 report to see how collaboration between biopharma and community oncology is transforming patient care, driving innovation and shaping the future of cancer treatment.

Download the Report

Always Advancing

From discovery through delivery, advancing care requires more than innovation alone. Together with our biopharma partners, we help bridge today’s challenges with tomorrow’s breakthroughs so patients can access the therapies they need.

The True Meaning of Partnership

With a shared purpose of Advancing Health Outcomes for All®, we partner with biopharma to deliver innovative therapies and accelerate access to the care patients need.

Advancing Specialty Access

CoverMyMeds helps connect specialty access and affordability workflows across the healthcare ecosystem to support faster access to prescribed therapies when patients need them most.

Accelerating Care Through Our Oncology Ecosystem

By connecting data-driven insights with deep therapeutic expertise, we help biopharma and community providers navigate complexity and bring state-of-the-art care closer to home.

Advancing Cell and Gene Therapy

InspiroGene by McKesson partners with biopharma to solve the complexities of commercializing cell and gene therapy — combining deep expertise, tailored logistics and a true understanding of every patient and product journey.

Advancing Precision and Personalized Medicine

Through precision-driven solutions and data-enabled technologies, we advance personalized medicine by helping deliver the right treatments to the right patients, faster.

Advancing New Therapies

Now Playing

The True Meaning of Partnership

Now Playing

Advancing Specialty Access

Now Playing

Accelerating Care Through Our Oncology Ecosystem

Now Playing

Advancing Cell and Gene Therapy

Now Playing

Advancing Precision and Personalized Medicine

Now Playing

Advancing New Therapies

Our Biopharma Focus Areas

Our solutions and services focus on removing barriers that can stand between patients and treatment — helping patients start and stay on therapy, accelerating clinical development, improving access to advanced treatments, and keeping high‑quality care available in local communities.

How does McKesson advance clinical discovery, research and clinical trials?

McKesson supports cancer research through a community‑based clinical trial infrastructure.
We partner with biopharma to advance the science of cancer treatments through our joint venture, Sarah Cannon Research Institute (SCRI).
With more than 200 clinical trial locations across 20+ states, we enable patients to participate in clinical research locally.
Leveraging Genospace, we advance precision medicine through clinical trial matching increasing accessibility for patients and accelerating trial enrollment.

What role does McKesson play in community care and delivery?

McKesson plays a critical role in preserving and strengthening community care by connecting scale, capabilities and expertise to help providers deliver high‑quality, accessible care while supporting affordability for patients and payers.
Through The US Oncology Network, we streamline logistical and administrative access to complex medications and support timely, high‑quality care for patients. 
We provide administrative support, including billing, collections and related services, enabling physicians to focus their time and attention on delivering high‑quality patient care. 
Our integrated technology platforms streamline practice workflows, support precision medicine, and reduce friction across the patient journey. Our comprehensive platform spans distribution, practice management, clinical documentation and decision making, and research to create connectivity that supports growth and innovation.

How does McKesson use real-world data and insights to advance biopharma?

Through Ontada and partnerships with The US Oncology Network, we provide responsibly governed real-world data, research and provider education to accelerate drug development, inform market strategies, and improve health outcomes. 

How does McKesson support drug and therapy delivery?

With Biologics by McKesson specialty pharmacy services, we simplify access to therapies and delivers personalized, high-touch support for cancer, cell and gene, and rare disease patients.
Through InspiroGene, we deliver complex cell and gene therapies directly to patients and providers, advancing innovative treatment delivery.

How is McKesson harnessing AI to strengthen patient care?

From workforce burnout to fragmented data, providers face unprecedented challenges, and emerging technologies with AI capabilities show promise in helping to simplify complexity. At McKesson, we are seeing remarkable adoption of solutions that are transforming care delivery including:

AI scribes that streamline documentation, cutting time spent in EMRs so providers can focus on patients.
Biomarker matching technology that accelerates treatment decisions and identifies clinical trial candidates faster.
Predictive analytics that help prevent acute-care utilization by identifying at-risk patients early.
Revenue cycle optimization tools that boost coding accuracy, reduce claim denials, and speed up reimbursements.

How McKesson Supports Biopharma

From clinical development to commercialization, our biopharma partners can leverage our expertise at any stage of their process.

Our Distribution Services

Our top-tier pharmaceutical distribution and logistics solutions are designed with our partners and their patients in mind. We partner with biopharma companies of all sizes to distribute new and established therapies accurately, safely, securely and on time. Additionally, we handle a wide range of product types and therapeutic areas, including specialty medications, branded drugs, cell and gene therapies, plasma products and generics.

Learn more

News & Stories